Test #1 Flashcards

1
Q

Uricostatic agents

A
  • allopurinol and febuxostat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Uricosuric agents

A
  • probenecid, salicylate, losartan

- increase the rate of excretion of uric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Enzymes for gout treatment

A

pegloticase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anti-inflammatory agents for gout

A

colchicine and indomethacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Allopurinol

A

Xanthine Oxidase Inhibitor
- reduces synthesis of urate
- oxypurinol is an active metabolite (long)
Effects
—prevents progression of gouty arthritis
—decrease nephropathy by decreasing stones
—increase acute gout flare
PK
—rapidly absorbed and long lasting (1/day)
—colchicine with to prevent acute flare
Adverse
—probenecid will increase clearance
—with warfarin - increase bleeding risk
—hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Febuxostat

A
- non-competitive xanthine oxidase
Uses
---hyperuricemia with gout
Adverse
---bad for liver, nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Probenecid

A
MoA
---inhibits transport of urate across URAT-1
Uses
---gout therapy 
---combined with more fluids, bicarb, colchicine
Adverse
---GI - peptic ulcer
---Salicylates will reduce efficacy
---blocks penicillin excretion
High doses are uricosuric not low doses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Losartan

A
  • moderate uricosuric agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pegloticase

A
- pegylated recombinant porcine uricase
Uses
---refractory gout
---not for chronic gout
Adverse
---BBW - anaphylaxis and hymolytic anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Colchicine

A

MoA
—anti-mitotic by interfering with microtubules
—prevents activation and migration of neutrophils
PK
—oral and metabolized by CYP3A4
Uses
—acute gout
—prevention while other agents are started
Adverse
—GI - stop if they continue
—Myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indomethacin

A
NSAID - inhibitor of COX 1/2
Adverse
--- narrow therapeutic window
--- 50% of SE
----severe frontal headache
---seizures, depression and psychosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hydroxychloroquine

A
Uses
---antimalarial drug
---anti-inflammatory agent and combined for RA
PK
---oral daily
Adverse
---GI and skin in short term
---retinal damage - get baseline exam
---decreases blood glucose
---don't use with psoriasis or prophyria
---hepatotoxic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sulfasalazine

A
Uses
---immune suprressive for RA
PK
---oral daily
---metabolized in gut and poorly  absorbed
Adverse
---GI and diarrhea
---skin rash
---blood dyscarsias/agranulocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Methotrexate

A
Uses
---RA with folate replacement
PK
---oral, SC
---once per week
---take 4-6 weeks for effect
MoA
---anti-folate to inhibite purine synthesis
---inhibits AICAR transformylase to increase adenosine
---reduces thymidine levels (pyrimidine)
Adverse
---hepatotoxicity with high doses
---teratogenic
---pulmonary toxicity
---alopecia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Leflunomide

A
MoA
---inhibits dihydro-orotate - inhibits pyrimidine
--- inhibits T-cell proliferation
Uses
---immunosuppressive agent
PK
---oral daily (prodrug to teriflunomide)
Adverse 
--- long half life causes much CYP450 inhibition
---carcinogenic and teratogenic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Minocycline

A
MoA
---tetracycline antibiotic
---inhibits metalloproteinases to decrease collegen degradation in RA
PK
---experimental
---twice daily oral
Adverse
--- dizziness and hyperpigmentation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Etanercept

A
- anti tumor necrosis factor alpha
MoA
---anti TNF alpha and stops binding to receptor
PK
---SC injection weekly with methotrexate
---short duration
Adverse
---headaches
---progressive multifocal leukoencephalopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Infliximab

A
MoA
---monoclonal antibody against TNF 
PK
---IV every  4-8 wks with  methotrexate
Adverse
---Cause hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Adalimumab

A
MoA
---Anti-TNF humanized antibiody
PK
---SC injection per 2 weeks
---for juvenile arthritis
Adverse
---demyelination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Abatacept

A
MoA
---CTLA-4 analog to antagonize CD28 receptor
---T cell inhibitor
PK
---SC injection weekly
---for moderate-severe RA
Adverse
---serious infection risk
---infusion reaciton
--- not used in those with COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Rituximab

A
MoA
---anti-CD20 monoclonal antibody
---inhibits B cells
PK
---IV two weeks apart then wait 6 months
---combination with methotrexate
Adverse
---infection risk is high 
---progressive multifocal leukoencephalopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

NSAIDS for Arthritis

A
  • Naproxen is safest

- usually not sufficient for RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Glucocorticoids for Arthritis

A
  • prednisone mostly
  • toxicity with long term use
  • used in combo for RA
  • bridging agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Triple Drug therapy

A
  • start with methotrexate
    • if no go then try hydroxychloroquine + sulfa
      • if no go then try all three
  • multiple drugs = synergistic effect and reduced side effects
25
Q

Side Effects of Biologic Agents for RA

A
  • Increased infection risk
  • Blood dyscrasias
  • Increased cancer incidence
  • GI, rash, headache
26
Q

Local Anesthetic Properties

A
  • weak bases
  • the charged form is the active form
  • lower pKa = more uncharged species
27
Q

Local Anesthetic MoA

A
  • block open Na channels along axons
  • is reversible
  • blockage is from inside the cell
    With progressive concentrations
    —excitation threshold increases
    —impulse conduction slows
    —action potential ability is abolished
  • blocks small C and B fibers first then larger fibers
  • pain blocked first then sensory then motor
  • epinephrine used to limit systemic absorption
28
Q

Potency of Local Anesthetics

A
  • potentcy is directly correlated to lipid solubility
  • Most to least
  • –Tetracaine, Bupivacaine, Ropivacaine, Lidocaine, Cocaine, Mepivacaine, Procaine
29
Q

Types of Local Blocks

A
  • Topical
  • Field - ring around wound area
  • Peripheral - upstream block
  • Spinal - within epidural space
30
Q

Clearance of Local Anesthetics

A
  • dependent on age, liver function and type

- esters (by cholinesteraces) are hydrolyzed faster than amino amides (by CYP 450)

31
Q

Adverse Effects of Local Anesthetics

A

Systemic Toxicity
—allergic deramatitis
—fatal anaphylaxis
—sedation, visual and auditory toxicity
—tonic-clonic convulsions
Neural toxicity
— Transient - with lidocaine, procaine and mepivacaine

32
Q

Drugs used to treat spasm

A
  • chlorzoxazone
  • cyclobenzaprine
  • orphenadrine
  • methocarbamol
  • diazepam
33
Q

Drugs used to treat spasticity

A
  • Baclofen
  • Tizanidine
  • Gabapentin
  • Botulinum toxin
  • Dantrolene
34
Q

Chlorzoxazone

A
  • anti-spasm drug
  • 60 min onset
  • 1 hour duration
35
Q

Methocarbamol

A
  • anti-spasm drug
  • 30 min onset and 1-2 hour duration
  • similar structure to tricyclic antidepressants
    Adverse
    —discoloration of urine
    —dizziness and loss of coordination
    —CNS depression and addiction
36
Q

Cyclobenzaprine

A
MoA
---reduces tonic somatic activity at alpha and gamma neurons
---noradrenergic and serotonergic
PK
---60 min onset and 12-24 hour duration
Adverse
---anticholinergic, drowsiness
---respiratory depression, hypoTN, flaccid paralysis, addiction
37
Q

Orphenadrine

A
  • anti-spasm drug
    MoA
    —anticholinergic - atropine like
38
Q

Baclophen

A

Uses
—decrease spasticity with MS and spinal injury
—hiccups and neuropathic pain
MoA
—GABAb receptor agonist to decrease substance P release
PK
—given intrathecally

39
Q

Tizanidine

A

Uses
—decrease spasticity with MS and spinal injury
MoA
—alpha 2 adrenergic agonist - inhibits release of excitatory neurotransmitters

40
Q

Gabapentin

A
MoA
---increases GABA biosynthesis
Uses
---reduce muscle spasticity
---reduce anxiety
41
Q

Diazepam

A

MoA
—agonist of GABAa receptors - presynaptic inhibition
Uses
—to calm patients

42
Q

Dantrolene

A
MoA
---reduces the release of Ca from SR in fast twitch muscle fibers - stopping contraction
Uses
---decrease spasticity with upper motor neuron lesions, strokes, spinal injury
---treat malignant hyperthermia
---treat neuroleptic malignant syndrome
Adverse
---causes excessive muscle weakness
---don't use with ALS pt
43
Q

Botulinum Toxin

A
MoA
---inhibits acetylcholine release from pre-synaptic terminal 
Uses
---decrease spasticity with cerebral palsy, stroke, MS
---treat excessive sweating
PK
---paralysis within 48 hours
---lasts for 12-16 weeks
Adverse
---excess weakness
---toxin absorption systemically
44
Q

What are the stages of ansethesia?

A

Stage 1
- conscious but drowsy
Stage 2
- unconscious but responds in a reflex fashion
Stage 3
- regular respiration, no spontaneous movement
Stage 4
- loss of respiration and vasomotor control = death
Current
- induction, maintenance and emergence

45
Q

Anesthesia effects on organs/tissues….

A
Cardiovascular
- systemic vasodilation
- myocardial suppression
Respiratory
- need for assisted ventilation
Hypothermia
46
Q

Inhaled anesthetics MoA

A
  • enhancement of inhibitory GABA-a

- inhibition of excitatory glutamate, nicotinic and 5-HT3

47
Q

Pharmacokinetics of Inhaled Anesthetics

A
  • effect takes place with equilibrium between alveolar gas and brain tissue
  • low blood solubility (less hydrophilic) have more rapid induction rates
  • the more blood soluble (more hydrophilic) the more drug that must be taken up to get to equilibrium
  • bulk uptake of a drug into the blood can accelerate induction (mainly in low solubility agents) - can increase uptake of a second drug by this method
  • pulmanary ventilation rate plays a major role in induction
  • recovery is prolonged with more soluble drugs
48
Q

Potency of Inhaled Anesthetics

A
  • the minimum alveolar concentration (MAC) required to induce anesthesia
  • the higher the MAC the lower the potency
  • MAC values are additive making combination treatments capable of using less drug amounts
  • Infancy, chronic alcohol, hypernatremia and sympathomimetics will decrease the potency
  • age, acute alcohol intake, pregnancy, opioids and hypothermia will increase potency
49
Q

Nitrous Oxide

A
Uses
---alone as sedative/analgesic
---in combo to reduce required doses
Advantages
---rapid acting
---minimal cardio effects
---reduces side effects of combo'd drug
Adverse
---not a good muscle relaxant
---cause diffusion hypoxia
---myelosuppression and teratogenic
50
Q

Halothane

A
Uses
---induction and maintenance in children
Advantages
---non-pungent and rapid
---muscle relaxant and bronchodilator
Adverse
---slow elimination
---cardiac depression and increases intracranial pressure
---can cause halothane hepatitis = immune response
51
Q

Isoflurane

A
Uses
---maintenance
Advantages
---maintains cardiac function
Adverse
---pungent
52
Q

Desflurane

A
Uses
---widely for maintenance
Advantages
---very rapid
---maintains cardiac function
Adverse
---pungent
53
Q

Sevoflurane

A
Uses
---induction and maintenance in children
Advantages
---low pungency
---maintains cardiac function
54
Q

Malignant hyperthermia Characteristics

A
  • triggered when exposed to halogenated anesthetics or succinylcholine
    Presentation
  • hypercapnia
  • muscle rigidity
  • tachycardia, hyperthermia, hyperkalemia
    Genetics
  • mutations in ryanodine receptors = excess Ca++
    Treatment
  • stop triggering drug
  • 100% O2
  • dantrolene
55
Q

Methohexital

A
- IV anesthetic
MoA
--- barbituate acting on GABA-a
PK
---onset 30 sec and duration 10 min
56
Q

Propofol

A
- IV anesthetic
MoA
---GABA-a agonist
PK
---onset 40 second and duration about 6 min
Adverse
---hypotension and respiratory depression
---pain at the injection site
57
Q

Etomidate

A
- IV anesthetic
MoA
---potentiates GABA-a currents
Uses
---induction and maintenance in pt's with hypotension
Adverse
---myoclonic movements
---adrenal insufficiency
58
Q

Ketamine

A
  • IV anesthetic
    MoA
    —NMDA receptor antagonist to block glutamate
    Uses
    —induciton and maintenance of children and pt’s with airway problems
    Adverse
    —CNS psychotomimetic - hallucinations, euphoria
    —tachycardia and hypersalivation